Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Susmita Haldar & Md Mehboob Alam. (2021) Designing curcumin-based non-linear optically active compounds. Molecular Physics 119:8.
Read now
Read now
Lucia Ruxandra Tefas, Bianca Sylvester, Ioan Tomuta, Alina Sesarman, Emilia Licarete, Manuela Banciu & Alina Porfire. (2017) Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach. Drug Design, Development and Therapy 11, pages 1605-1621.
Read now
Read now
Ying-Ti Wang, Hsiao-Sheng Liu & Chun-Li Su. (2014) Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest. International Journal of Food Sciences and Nutrition 65:3, pages 368-374.
Read now
Read now
Mostafa I. Waly, Mansour S. Al Moundhri & Badreldin H. Ali. (2011) Effect of Curcumin on Cisplatin- and Oxaliplatin-Induced Oxidative Stress in Human Embryonic Kidney (HEK) 293 Cells. Renal Failure 33:5, pages 518-523.
Read now
Read now
Michael A Lea. (2010) Recently Identified and Potential Targets for Colon Cancer Treatment. Future Oncology 6:6, pages 993-1002.
Read now
Read now
Articles from other publishers (55)
Hamdi Nsairat, Areej M Jaber, Haya Faddah & Somaya Ahmad. (2024) Oleuropein impact on colorectal cancer. Future Science OA 10:1.
Crossref
Crossref
Hossein Shahdadi Sardou, Seyedeh Elnaz Nazari, Mohammadreza Abbaspour, Abbas Akhgari, Afsana Sheikh, Prashant Kesharwani & Amirhossein Sahebkar. (2023) Nano-curcumin formulations for targeted therapy of colorectal cancer. Journal of Drug Delivery Science and Technology 88, pages 104943.
Crossref
Crossref
Zhenhao Zhang, Wei Wu & Zengwu Shao. (2023) NOTCH Signaling in Osteosarcoma. Current Issues in Molecular Biology 45:3, pages 2266-2283.
Crossref
Crossref
Fahadul Islam, Saikat Mitra, Talha Bin Emran, Zidan Khan, Nikhil Nath, Rajib Das, Rohit Sharma, Ahmed Abdullah Al Awadh, Moon Nyeo Park & Bonglee Kim. (2022) Natural Small Molecules in Gastrointestinal Tract and Associated Cancers: Molecular Insights and Targeted Therapies. Molecules 27:17, pages 5686.
Crossref
Crossref
Hui Lin, Shuo Tian, Yizhong Peng, Ling Wu, Yan Xiao, Xiangcheng Qing & Zengwu Shao. (2022) IGF Signaling in Intervertebral Disc Health and Disease. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Md. Tanvir Kabir, Md. Habibur Rahman, Rokeya Akter, Tapan Behl, Deepak Kaushik, Vineet Mittal, Parijat Pandey, Muhammad Furqan Akhtar, Ammara Saleem, Ghadeer M. Albadrani, Mohamed Kamel, Shaden A.M. Khalifa, Hesham R. El-Seedi & Mohamed M. Abdel-Daim. (2021) Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers. Biomolecules 11:3, pages 392.
Crossref
Crossref
Nor Isnida Ismail, Iekhsan Othman, Faridah Abas, Nordin H. Lajis & Rakesh Naidu. (2020) The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells. Molecules 25:17, pages 3798.
Crossref
Crossref
Constanze Buhrmann, Ajaikumar Kunnumakkara, Bastian Popper, Muhammed Majeed, Bharat Aggarwal & Mehdi Shakibaei. (2020) Calebin A Potentiates the Effect of 5-FU and TNF-β (Lymphotoxin α) against Human Colorectal Cancer Cells: Potential Role of NF-κB. International Journal of Molecular Sciences 21:7, pages 2393.
Crossref
Crossref
Clara Bik-San Lau & Grace Gar-Lee Yue. 2020. Natural Products for Cancer Chemoprevention. Natural Products for Cancer Chemoprevention
209
239
.
Chun‑Jung ChoChing‑Wei YangChia‑Lun WuJar‑Yi HoCheng‑Ping YuSheng‑Tang WuDah‑Shyong Yu. (2019) The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. Oncology Letters.
Crossref
Crossref
Meigui Huang, Cuiping Liang, Chen Tan, Shuai Huang, Ruifeng Ying, Yaosong Wang, Zhenjiong Wang & Yifan Zhang. (2019) Liposome co-encapsulation as a strategy for the delivery of curcumin and resveratrol. Food & Function 10:10, pages 6447-6458.
Crossref
Crossref
Se-Chun Liao, Hsiu-Wen Hsu, Kun-Lin Chuang, Zi-Yi Huang, Kuan-Ting Lin, Wei-Hsiang Hsu, Kai-Hsun Chang, Chi-Yin F. Huang & Chun-Li Su. (2019) Using the Pleiotropic Characteristics of Curcumin to Validate the Potential Application of a Novel Gene Expression Screening Platform. Nutrients 11:6, pages 1397.
Crossref
Crossref
Mahtab Zangui, Stephen L. Atkin, Muhammed Majeed & Amirhossein Sahebkar. (2019) Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art. Pharmacological Research 141, pages 343-356.
Crossref
Crossref
Adhip P.N. Majumdar. 2019. Animal Models in Cancer Drug Discovery. Animal Models in Cancer Drug Discovery
293
307
.
Ying Wang, Pengjun Zhou, Shurong Qin, Dandan Xu, Yukun Liu, Wuyu Fu, Bibo Ruan, Li Zhang, Yi Zhang, Xiao Wang, Yuwei Pan, Sheng Wang, Haizhao Yan, Jinhong Qin, Xiaoyan Wang, Qiuying Liu, Zhiyun Du, Zhong Liu & Yifei Wang. (2018) The Curcumin Analogs 2-Pyridyl Cyclohexanone Induce Apoptosis via Inhibition of the JAK2–STAT3 Pathway in Human Esophageal Squamous Cell Carcinoma Cells. Frontiers in Pharmacology 9.
Crossref
Crossref
Denisa Baci, Antonino Bruno, Barbara Bassani, Matilde Tramacere, Lorenzo Mortara, Adriana Albini & Douglas M. Noonan. (2018) Acetyl- l -carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways. Cancer Letters 429, pages 100-116.
Crossref
Crossref
Yung‐Ting Hsiao, Chao‐Lin Kuo, Jen‐Jyh Lin, Wen‐Wen Huang, Shu‐Fen Peng, Fu‐Shin Chueh, Da‐Tian Bau & Jing‐Gung Chung. (2018)
Curcuminoids combined with gefitinib mediated apoptosis and autophagy of human oral cancer SAS cells
in vitro
and reduced tumor of SAS cell xenograft mice
in vivo
. Environmental Toxicology 33:8, pages 821-832.
Crossref
Crossref
Tapan Behl, Chanchal Kumar, Roshan Kumar Singh, Taruna Katyal Arora & Sandeep Arora. (2018) Traditional and Novel Herbal Drugs Emerging as Potent Novel Combinations for Managing Morbidities by Pharmacological and Mechanistic Studies. Journal of Pharmaceutical Technology, Research and Management 6:1, pages 31-53.
Crossref
Crossref
Yung-Ting Hsiao, Chao-Lin Kuo, Fu-Shin Chueh, Kuo-Ching Liu, Da-Tian Bau & Jing-Gung Chung. (2018) Curcuminoids Induce Reactive Oxygen Species and Autophagy to Enhance Apoptosis in Human Oral Cancer Cells. The American Journal of Chinese Medicine 46:05, pages 1145-1168.
Crossref
Crossref
Sumit Mukherjee, Priya Ranjan Debata, Rahman Hussaini, Kaushiki Chatterjee, Juliet N.E. Baidoo, Samay Sampat, Anita Szerszen, Joseph P. Navarra, Jimmie Fata, Elena Severinova, Probal Banerjee & Mario R. Castellanos. (2017) Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression. Oncotarget 8:37, pages 60904-60916.
Crossref
Crossref
Longzhu Piao, Sumit Mukherjee, Qing Chang, Xiujie Xie, Hong Li, Mario R. Castellanos, Probal Banerjee, Hassan Iqbal, Ryan Ivancic, Xueqian Wang, Theodoros N. Teknos & Quintin Pan. (2016) TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget 8:36, pages 60025-60035.
Crossref
Crossref
Jin Xin, Wang Jue, Shen Huifen, Ran Ran, Xu Kai, Tong Xiangming, Zhang Weiping & Feng Li. (2017) Curcumin co-treatment ameliorates resistance to gefitinib in drug-resistant NCI-H1975 lung cancer cells. Journal of Traditional Chinese Medicine 37:3, pages 355-360.
Crossref
Crossref
Yan Li, Jinghui Wang, Feng Lin, Yinfeng Yang & Su-Shing Chen. (2017) A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines. PLOS ONE 12:1, pages e0169363.
Crossref
Crossref
Yuxia Zhang, Yan Bai, Huali Chen, Yuanrui Huang, Pei Yuan & Liangke Zhang. (2017) Preparation of a colon-specific sustained-release capsule with curcumin-loaded SMEDDS alginate beads. RSC Advances 7:36, pages 22280-22285.
Crossref
Crossref
Avudaiappan Maran, Michael Yaszemski, Ananiy Kohut & Andriy Voronov. (2016) Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help?. Materials 9:7, pages 520.
Crossref
Crossref
Dong ChenFang DaiZhehang ChenSaisai WangXiaobin ChengQinsong ShengJianjiang LinWenbin Chen. (2016) Dimethoxy Curcumin Induces Apoptosis by Suppressing Survivin and Inhibits Invasion by Enhancing E-Cadherin in Colon Cancer Cells. Medical Science Monitor 22, pages 3215-3222.
Crossref
Crossref
Sin-Yeang Teow, Kitson Liew, Syed A. Ali, Alan Soo-Beng Khoo & Suat-Cheng Peh. (2016)
Antibacterial Action of Curcumin against
Staphylococcus aureus
: A Brief Review
. Journal of Tropical Medicine 2016, pages 1-10.
Crossref
Crossref
MING-NA LIU, AI-YUN LIU, FENG-HUA PEI, XIAO MA, YU-JING FAN, YA-JU DU & BING-RONG LIU. (2015) Functional mechanism of the enhancement of 5-fluorouracil sensitivity by TUSC4 in colon cancer cells. Oncology Letters 10:6, pages 3682-3688.
Crossref
Crossref
MING-NA LIU, AI-YUN LIU, YA-JU DU, FENG-HUA PEI, XIN-HONG WANG, JING CHEN, DAN LIU & BING-RONG LIU. (2015) Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells. Molecular Medicine Reports 12:1, pages 1189-1196.
Crossref
Crossref
J. G. Devassy, I. D. Nwachukwu & P. J. H. Jones. (2015) Curcumin and cancer: barriers to obtaining a health claim. Nutrition Reviews 73:3, pages 155-165.
Crossref
Crossref
Wei Scarano, Paul de Souza & Martina H. Stenzel. (2015) Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer. Biomaterials Science 3:1, pages 163-174.
Crossref
Crossref
Shravanti Mukherjee, Shilpi Saha, Argha Manna, Minakshi Mazumdar, Samik Chakraborty, Shrutarshi Paul & Tanya Das. (2014) Targeting Cancer Stem Cells by Phytochemicals: a Multimodal Approach to Colorectal Cancer. Current Colorectal Cancer Reports 10:4, pages 431-441.
Crossref
Crossref
Ganesan Ramamoorthi & Nageswaran Sivalingam. (2014) Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy. Tumor Biology 35:8, pages 7295-7305.
Crossref
Crossref
Manhong Tan, Jia Luo & Ying Tian. (2014) Delivering curcumin and gemcitabine in one nanoparticle platform for colon cancer therapy. RSC Adv. 4:106, pages 61948-61959.
Crossref
Crossref
S. Uday Kumar, I. Matai, P. Dubey, B. Bhushan, A. Sachdev & P. Gopinath. (2014) Differentially cross-linkable core–shell nanofibers for tunable delivery of anticancer drugs: synthesis, characterization and their anticancer efficacy. RSC Adv. 4:72, pages 38263-38272.
Crossref
Crossref
Meng SI, Jie ZHAO, Xin LI, Ji-guang TIAN, Yong-gang LI & Jian-min LI. (2013) Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein. Chinese Medical Journal 126:21, pages 4116-4123.
Crossref
Crossref
QIN DU, BING HU, HONG-MEI AN, KE-PING SHEN, LING XU, SHAN DENG & MENG-MENG WEI. (2013) Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncology Reports 29:5, pages 1851-1858.
Crossref
Crossref
Sivapriya Ponnurangam, David Standing, Parthasarathy Rangarajan & Dharmalingam Subramaniam. (2013) Tandutinib Inhibits the Akt/mTOR Signaling Pathway to Inhibit Colon Cancer Growth. Molecular Cancer Therapeutics 12:5, pages 598-609.
Crossref
Crossref
X.Z. Cai, W.Y. Huang, Y. Qiao, S.Y. Du, Y. Chen, D. Chen, S. Yu, R.C. Che, N. Liu & Y. Jiang. (2013) Inhibitory effects of curcumin on gastric cancer cells: A proteomic study of molecular targets. Phytomedicine 20:6, pages 495-505.
Crossref
Crossref
B S Vinod, J Antony, H H Nair, V T Puliyappadamba, M Saikia, S Shyam Narayanan, A Bevin & R John Anto. (2013) Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil. Cell Death & Disease 4:2, pages e505-e505.
Crossref
Crossref
Yuanrui Huang, Rui Tian, Wenjing Hu, Yuntao Jia, Jingqing Zhang, Huiming Jiang & Liangke Zhang. (2013) A novel plug-controlled colon-specific pulsatile capsule with tablet of curcumin-loaded SMEDDS. Carbohydrate Polymers 92:2, pages 2218-2223.
Crossref
Crossref
Min‐Bin Chen, Xiao‐Yang Wu, Guo‐Qing Tao, Chao‐Ying Liu, Jian Chen, Li‐Qiang Wang & Pei‐Hua Lu. (2012)
Perifosine sensitizes curcumin‐induced anti‐colorectal cancer effects by targeting multiple signaling pathways both
in vivo
and
in vitro
. International Journal of Cancer 131:11, pages 2487-2498.
Crossref
Crossref
N Rocks, S Bekaert, I Coia, G Paulissen, M Gueders, B Evrard, J-C Van Heugen, P Chiap, J-M Foidart, A Noel & D Cataldo. (2012) Curcumin–cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. British Journal of Cancer 107:7, pages 1083-1092.
Crossref
Crossref
Yonggang Li, Jingru Zhang, Daoxin Ma, Lei Zhang, Meng Si, Han Yin & Jianmin Li. (2012) Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch‐1 signaling. The FEBS Journal 279:12, pages 2247-2259.
Crossref
Crossref
Dennis Ma, Phillip Tremblay, Kevinjeet Mahngar, Jonathan Collins, Tomas Hudlicky & Siyaram Pandey. (2011) Selective Cytotoxicity against Human Osteosarcoma Cells by a Novel Synthetic C-1 Analogue of 7-Deoxypancratistatin Is Potentiated by Curcumin. PLoS ONE 6:12, pages e28780.
Crossref
Crossref
Erika Ferrari, Francesca Pignedoli, Carol Imbriano, Gaetano Marverti, Valentina Basile, Ettore Venturi & Monica Saladini. (2011) Newly Synthesized Curcumin Derivatives: Crosstalk between Chemico-physical Properties and Biological Activity. Journal of Medicinal Chemistry 54:23, pages 8066-8077.
Crossref
Crossref
Jeffrey D Altenburg, Andrew A Bieberich, Colin Terry, Kevin A Harvey, Justin F VanHorn, Zhidong Xu, V Jo Davisson & Rafat A Siddiqui. (2011) A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone. BMC Cancer 11:1.
Crossref
Crossref
Stacey L Fossey, Misty D Bear, Jiayuh Lin, Chenglong Li, Eric B Schwartz, Pui-Kai Li, James R Fuchs, Joelle Fenger, William C Kisseberth & Cheryl A London. (2011) The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer 11:1.
Crossref
Crossref
Zhiyun He, Dharmalingam Subramaniam, Satish Ramalingam, Animesh Dhar, Russell G. PostierShahid Umar, Youcheng ZhangShrikant Anant. (2011) Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. American Journal of Physiology-Gastrointestinal and Liver Physiology 301:5, pages G929-G937.
Crossref
Crossref
Otito F. Iwuchukwu, Ronald J. Tallarida & Swati Nagar. (2011) Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells. Life Sciences 88:23-24, pages 1047-1054.
Crossref
Crossref
Shailender Singh Kanwar, Yingjie Yu, Jyoti Nautiyal, Bhaumik B. Patel, Subhash Padhye, Fazlul H. Sarkar & Adhip P. N. Majumdar. (2010) Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells. Pharmaceutical Research 28:4, pages 827-838.
Crossref
Crossref
Christine Kaefer & John Milner. 2011. Herbal Medicine. Herbal Medicine
361
382
.
Sigrid A Rajasekaran. (2011) Therapeutic potential of curcumin in gastrointestinal diseases. World Journal of Gastrointestinal Pathophysiology 2:1, pages 1.
Crossref
Crossref
Murielle Mimeault & Surinder K Batra. (2011) Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine 6:1, pages 31.
Crossref
Crossref
Brian Markle, Elizabeth J. May & Adhip P. N. Majumdar. (2010) Do nutraceutics play a role in the prevention and treatment of colorectal cancer?. Cancer and Metastasis Reviews 29:3, pages 395-404.
Crossref
Crossref